Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-038194
Filing Date
2024-08-22
Accepted
2024-08-22 14:45:09
Documents
3
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1724352301.html 3  
1 FORM 3 wk-form3_1724352301.xml 3 2211
2 EX-24 poa_phjohnsonxs.htm EX-24 631
3 poa_phjohnsonxs001.jpg GRAPHIC 235935
  Complete submission text file 0001628280-24-038194.txt   329359
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3515 LYMAN BLVD. CHASKA MN 55318
Business Address
Johnson Paul Harold (Reporting) CIK: 0002034858 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27446 | Film No.: 241231602